Log In
Print this Print this

Seala (formerly VG101)

  Manage Alerts
Collapse Summary General Information
Company Bionovo Inc.
DescriptionSelective estrogen receptor 2 (ESR2) agonist
Molecular Target Estrogen receptor 2 (ESR2)
Mechanism of ActionEstrogen receptor beta agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMenopause
Indication DetailsTreat menopausal vaginal dryness
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today